Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fospropofol vs midazolam for ICU sedation
ChiCTR2300072688Phase 4Not yet recruiting
- Sponsor
- The First Hospital of Hebei Medical University
- Start
- May 2023
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of fospropofol disodium in Sedation requirement (2 arms), sponsored by The First Hospital of Hebei Medical University. Primary endpoint: Time to achieve target sedation. Planned start May 2023; status: not yet recruiting.
02
Drugs
fospropofol disodium
03
Conditions
Sedation requirement
Beyond the preview
Go deeper on ChiCTR2300072688.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300072688.